Acepodia and JW Therapeutics Enter into Option and License Agreement for Off-the-shelf NK Cell Therapies

NEXT STORY
Worldwide Outlook on the Medical and Lab Refrigerator Industry to 2027 – Featuring Felix Storch, Follett & Helmer Scientific Among Others
PREV STORY
Arch Biopartners Engages Global CRO to Conduct LSALT peptide (Metablok) Phase II trial for Treatment of Complications in COVID-19 Patients in the U.S.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Zealand Pharma doses first patient in Phase 3 trial with dasiglucagon for the treatment of congenital hyperinsulinism

author_avatar
NASDAQ Market News

Leap Therapeutics to Present at the 2017 Ladenburg Thalmann Healthcare Conference

CAMBRIDGE, Mass., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology ...

author_avatar
NASDAQ Market News

The Foundation for Women’s Cancer and TESARO Announce 2nd Year of Partnership Supporting the National Race to End Women’s Cancer

CHICAGO and WALTHAM, Mass., Oct. 18, 2017 (GLOBE NEWSWIRE) -- The Foundation for Women’s ...

author_avatar
NASDAQ Market News